Executive record

Sean Bohen, M.D., Ph.D.

Director, President and Chief Executive Officer at Olema Pharmaceuticals, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:sean-bohen-m-d-ph-dVersion: public-0As of: 2026-09-30

Not yet claimed8 published Claims3 sources
  • Executive
  • Director

Key Claims

Biography

Dr. Bohen serves as President, Chief Executive Officer and Director of Olema Pharmaceuticals. His biography is referenced in Proposal No. 1 Election of Directors and is not detailed in this section.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Current · dates not publishedPresident and Chief Executive Officer · Olema Pharmaceuticals, Inc.
  2. 2026 to end not publishedExecutive title: President, Chief Executive Officer and Director · Organization not publishedOLMA DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. OLMA DEF 14A executive officers

    sec filing · Source published: Apr 29, 2026 · Retrieved: May 5, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at Olema Pharmaceuticals, Inc. · Claim reviewed: May 5, 2026
    • Executive title: Executive title: President, Chief Executive Officer and Director · Claim reviewed: May 5, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026

  2. Open source

    sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 12, 2026

    Supports 2 claims
    • Professional Role: President and Chief Executive Officer at Olema Pharmaceuticals, Inc. · Claim reviewed: Sep 12, 2026
    • Professional Role: Director, President and Chief Executive Officer at Olema Pharmaceuticals, Inc. · Claim reviewed: Sep 12, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Olema Pharmaceuticals, Inc. · Claim reviewed: Sep 12, 2026